Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
about
Inositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice.Update on Alzheimer's disease: recent findings and treatments.Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease.Muscarinic M(1) agonists in the treatment of Alzheimer's disease.The effects of sesquiterpenes-rich extract of Alpinia oxyphylla Miq. on amyloid-β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice.An assessment of the present and future roles of non-ligand gated ion channel modulators as CNS therapeutics.Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain.Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphineTherapeutic approaches to age-associated neurocognitive disordersNeurophysiological predictors of long term response to AChE inhibitors in AD patientsEffect of pesticide bendiocarbamate on distribution of acetylcholine- and butyrylcholine-positive nerves in rabbit's thymus.CNS gene therapy and a nexus of complexity: systems and biology at a crossroads.Caffeine inhibits acetylcholinesterase, but not butyrylcholinesteraseInhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons.Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer's.Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon rugosus.Effects of bis(7)-tacrine on spontaneous synaptic activity and on the nicotinic ACh receptor of Torpedo electric organ.Effects of donepezil (Aricept) on the rapid eye movement sleep of normal subjects.Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary.Effects of green tea polyphenol on cognitive and acetylcholinesterase activities.Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test.
P2860
Q28187990-2CFC8A42-192F-4A12-B767-94FF3E6D6659Q32162583-E707B9CC-FEF3-46C9-8157-C5DD6A1E93EEQ33727296-F9E46569-763D-4679-8BD8-9BE86A1C2F97Q33821291-CE0E37C2-1C00-4B43-A7A4-74DE5831294FQ34075102-48845FD6-8AF1-41A4-B7DD-DE3E63D7606AQ34080245-CEEE715D-A0CF-4182-83A0-7C1DAE63CA2EQ34182362-D5D29966-CC98-4DB9-AF0A-B6382677A673Q34415768-2F2D2031-F21C-4F67-A76B-7C3AF4064515Q34648742-E545B0F9-3790-4143-B19C-BF1F0FAF9E3CQ35023045-31A4675A-E908-40E0-B18A-A9D55BB61CACQ35236387-E277011E-66E3-44DB-A5FD-3BCD2541F2F7Q35489421-BC5660FB-DD0D-479B-ACDA-8106F56EA926Q35771424-27415527-BB91-4B38-9DFC-CD796FAB5141Q36485942-340BD0B5-6DE2-4A98-9975-B34B0A1ADB1BQ36913687-7A03F55B-4ED3-4438-AAB7-9F0E7E87B6FFQ38217301-2A95AC05-5085-4488-8852-658D929391F7Q38395251-F8F8E83D-03B2-443F-8DFE-B7D704DD422FQ38599650-EA0A41EF-E67C-4275-9217-3419FF8B6789Q41860013-9FEB8846-111D-4ECF-A14A-4DE0508B8B48Q42176085-487FAE39-A2D8-4A2B-AA71-E46014BB8FBCQ43657488-A4B35676-8DC8-4361-B815-08EC324F7506Q44016504-D0284A33-F429-4FEC-863B-B4EEB77D3025Q44778152-92B2EC9C-C95F-438D-9142-2F5D4A49C513Q45075815-3D31DA43-882D-4BF2-A6EC-7938ECBB2646Q51955427-41F5CB46-0921-4670-8706-C35068BCCAE3
P2860
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@ast
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@en
type
label
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@ast
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@en
prefLabel
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@ast
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@en
P2093
P2860
P356
P1476
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
@en
P2093
P2860
P304
P356
10.1345/APH.18211
P407
P577
1999-04-01T00:00:00Z